uniQure QURE Total debt

Total debt at other companies

Sarepta Therapeutics, Inc.SRPT

$198.23M-7.6%

Taysha Gene Therapies, Inc.TSHA

$68.55M+11.2%

PTC TherapeuticsPTCT

$395.09M+0.1%

Design Therapeutics, Inc.DSGN

$2.73M+27.7%

Candel Therapeutics, Inc.CADL

$2.84M-73.9%

RegenxbioRGNX

$68.95M-11.3%

FAQ

What is uniQure's total debt?

uniQure (QURE) reported total debt of $62.83M in Q2 2026.

How has uniQure's total debt changed year-over-year?

uniQure's total debt decreased by 5.8% year-over-year, from $66.7M to $62.83M.

What is the long-term trend for uniQure's total debt?

Over 5 years (2020 to 2025), uniQure's total debt has grown at a -2.4% compound annual growth rate (CAGR), from $71.54M to $63.39M.

What does total debt mean?

Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.